Covid-19 Research

Short Communication

Preventing COVID-19 Infection by Complementary Medicine and Oral Health

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Short Communication
Subject Medicine Group
OCLC JBRES Record
Scilla Sparabombe, Stefano Sarri*, Enrica Scagnetto and Mario Giannoni
Issue: Volume6-Issue1
Pages: 120-128
Received: 2025-01-08
Accepted: 2025-01-29
Published: 2025-01-31

Abstract

It’s possible that the mechanisms of natural phytotherapeutic remedies used in dental care can prevent the SARS-COV2 virus infection or minimize its clinical manifestations through the modulation of the immune system and counteract viral absorption at the cellular level.

Uncaria Tomentosa and Echinacea are plants with antiviral, antibacterial and immunomodulatory properties. Their main active components are alkaloids, glycosides, triterpenes, polysaccharides which favor immunological, anti-inflammatory, vulnerary activity.

Uncaria Tormetosa acts on a biochemical level as a competitor of the SARS-COV2 virus; Echinacea enhances and modulates the immune response and inhibits viral replication thanks to the flavonoid quercetin.

The use of natural substances could represent a considerable help in countering the coronavirus pandemic. Appropriate clinical studies are desirable to confirm what has been described.

FullText HTML FullText PDF DOI: 10.37871/jbres2063 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2025 Sparabombe S, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Sparabombe S, Sarri S, Scagnetto E, Giannoni M. Preventing COVID-19 Infection by Complementary Medicine and Oral Health. J Biomed Res Environ Sci. 2025 Jan 31; 6(1): 120-128. doi: 10.37871/ jbres2063, Article ID: JBRES2063, Available at: https://www.jelsciences.com/articles/jbres2063.pdf

Subject area(s)

Alternative MedicineDentistry

References

  1. Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021 Apr 22;28(3):e299-e318. doi: 10.1097/MJT.0000000000001377. Erratum in: Am J Ther. 2021 Nov-Dec 01;28(6):e813. doi: 10.1097/MJT.0000000000001458. PMID: 34375047; PMCID: PMC8088823.
  2. Hu GY, Liang CA, Lin PC, Lin CY. Ivermectin's Role in the Prevention of COVID-19: A Systematic Review and Meta-Analysis. J Clin Pharmacol. 2023 Mar;63(3):288-297. doi: 10.1002/jcph.2178. Epub 2022 Dec 10. PMID: 36399336.
  3. Akhter J, Quéromès G, Pillai K, Kepenekian V, Badar S, Mekkawy AH, Frobert E, Valle SJ, Morris DL. The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2. Viruses. 2021 Mar 6;13(3):425. doi: 10.3390/v13030425. PMID: 33800932; PMCID: PMC7999995.
  4. Majid S, Khan MS, Rashid S, Niyaz A, Farooq R, Bhat SA, Wani HA, Qureshi W. COVID-19: Diagnostics, Therapeutic Advances, and Vaccine Development. Curr Clin Microbiol Rep. 2021;8(3):152-166. doi: 10.1007/s40588-021-00157-9. Epub 2021 Feb 15. PMID: 33614398; PMCID: PMC7883962.
  5. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021 Jan 29;13(2):202. doi: 10.3390/v13020202. PMID: 33572857; PMCID: PMC7911532.
  6. Kisielinski K, Giboni P, Prescher A, Klosterhalfen B, Graessel D, Funken S, Kempski O, Hirsch O. Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards? Int J Environ Res Public Health. 2021 Apr 20;18(8):4344. doi: 10.3390/ijerph18084344. PMID: 33923935; PMCID: PMC8072811.
  7. Jefferson T, Dooley L, Ferroni E, Al-Ansary LA, van Driel ML, Bawazeer GA, Jones MA, Hoffmann TC, Clark J, Beller EM, Glasziou PP, Conly JM. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6. PMID: 36715243; PMCID: PMC9885521.
  8. Allen DW. Covid-19 Lockdown Cost/Benefits: A Critical Assessment of the Literature. Int J Econ Bus. 2022 Jan 2;29(1):1–32.
  9. Korosec CS, Farhang-Sardroodi S, Dick DW, Gholami S, Ghaemi MS, Moyles IR, Craig M, Ooi HK, Heffernan JM. Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex. Sci Rep. 2022 Dec 8;12(1):21232. doi: 10.1038/s41598-022-25134-0. PMID: 36481777; PMCID: PMC9732004.
  10. Florentino PTV, Millington T, Cerqueira-Silva T, Robertson C, de Araújo Oliveira V, Júnior JBS, Alves FJO, Penna GO, Vital Katikireddi S, Boaventura VS, Werneck GL, Pearce N, McCowan C, Sullivan C, Agrawal U, Grange Z, Ritchie LD, Simpson CR, Sheikh A, Barreto ML, Rudan I, Barral-Netto M, Paixão ES. Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study. Lancet Infect Dis. 2022 Nov;22(11):1577-1586. doi: 10.1016/S1473-3099(22)00451-0. Epub 2022 Aug 8. PMID: 35952702; PMCID: PMC9359673.
  11. Uschner D, Bott M, Lagarde WH, Keating J, Tapp H, Berry AA, Seals AL, Munawar I, Schieffelin J, Yukich J, Santacatterina M, Gunaratne M, Fette LM, Burke B, Strylewicz G, Edelstein SL, Ahmed A, Miller K, Sanders JW, Herrington D, Weintraub WS, Runyon MS, On Behalf Of The Covid-Community Research Partnership. Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina. Vaccines (Basel). 2022 Nov 13;10(11):1922. doi: 10.3390/vaccines10111922. PMID: 36423018; PMCID: PMC9695352.
  12. Liew J, Gianfrancesco M, Harrison C, Izadi Z, Rush S, Lawson-Tovey S, Jacobsohn L, Ja C, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Schäfer M, Frãzao-Mateus E, Bulina I, Stafford F, Tufan A, Graver C, Yardımcı GK, Zepa J, Al Emadi S, Cook C, Abutiban F, Dey D, Katigbak G, Kaufman L, Kowalski E, Martínez-Martínez MU, Patel NJ, Reyes-Cordero G, Salido E, Smith E, Snow D, Sparks J, Wise L, Bhana S, Gore-Massy M, Grainger R, Hausmann J, Sirotich E, Sufka P, Wallace Z, Machado PM, Robinson PC, Yazdany J. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry. RMD Open. 2022 Apr;8(1):e002187. doi: 10.1136/rmdopen-2021-002187. PMID: 35387864; PMCID: PMC8987210.
  13. Keehner J, Horton LE, Binkin NJ, Laurent LC; SEARCH Alliance; Pride D, Longhurst CA, Abeles SR, Torriani FJ. Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce. N Engl J Med. 2021 Sep 30;385(14):1330-1332. doi: 10.1056/NEJMc2112981. Epub 2021 Sep 1. PMID: 34469645; PMCID: PMC8451183.
  14. Feyaerts AF, Luyten W. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? Nutrition. 2020 Nov-Dec;79-80:110948. doi: 10.1016/j.nut.2020.110948. Epub 2020 Jul 25. PMID: 32911430; PMCID: PMC7381407.
  15. Szarpak L, Filipiak KJ, Gasecka A, Gawel W, Koziel D, Jaguszewski MJ, Chmielewski J, Gozhenko A, Bielski K, Wroblewski P, Savytskyi I, Szarpak L, Rafique Z. Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis. Cardiol J. 2022;29(2):188-196. doi: 10.5603/CJ.a2021.0122. Epub 2021 Oct 13. PMID: 34642923; PMCID: PMC9007480.
  16. Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, Talbot PJ. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2019 Dec 20;12(1):14. doi: 10.3390/v12010014. PMID: 31861926; PMCID: PMC7020001.
  17. Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID-19 disease: A review article. Dermatol Ther. 2021 Jan;34(1):e14578. doi: 10.1111/dth.14578. Epub 2020 Dec 13. PMID: 33236823; PMCID: PMC7744903.
  18. Gomes‐Filho IS, Cruz SSD, Trindade SC, Passos‐Soares JDS, Carvalho‐Filho PC, Figueiredo ACMG, et al. Periodontitis and respiratory diseases: A systematic review with meta‐analysis. Oral Dis. 2020 Mar;26(2):439–46.
  19. Sampson V, Kamona N, Sampson A. Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? Br Dent J. 2020 Jun;228(12):971-975. doi: 10.1038/s41415-020-1747-8. PMID: 32591714; PMCID: PMC7319209.
  20. Gupta S, Mohindra R, Singla M, Khera S, Sahni V, Kanta P, Soni RK, Kumar A, Gauba K, Goyal K, Singh MP, Ghosh A, Kajal K, Mahajan V, Bhalla A, Sorsa T, Räisänen I. The clinical association between Periodontitis and COVID-19. Clin Oral Investig. 2022 Feb;26(2):1361-1374. doi: 10.1007/s00784-021-04111-3. Epub 2021 Aug 27. PMID: 34448073; PMCID: PMC8390180.
  21. Minich DM, Hanaway PJ. The Functional Medicine Approach to COVID-19: Nutrition and Lifestyle Practices for Strengthening Host Defense. Integr Med (Encinitas). 2020 May 9;19(Suppl 1):54-62. PMID: 33041708; PMCID: PMC7482148.
  22. Shahzad F, Anderson D, Najafzadeh M. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection. Nutrients. 2020 Aug 25;12(9):2573. doi: 10.3390/nu12092573. PMID: 32854262; PMCID: PMC7551890.
  23. Cannalire R, Cerchia C, Beccari AR, Di Leva FS, Summa V. Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities. J Med Chem. 2022 Feb 24;65(4):2716-2746. doi: 10.1021/acs.jmedchem.0c01140. Epub 2020 Nov 13. PMID: 33186044; PMCID: PMC7688049.
  24. Grimes SL, Denison MR. The Coronavirus helicase in replication. Virus Res. 2024 Aug;346:199401. doi: 10.1016/j.virusres.2024.199401. Epub 2024 May 31. PMID: 38796132; PMCID: PMC11177069.
  25. Boozari M, Hosseinzadeh H. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res. 2021 Feb;35(2):864-876. doi: 10.1002/ptr.6873. Epub 2020 Sep 27. PMID: 32985017.
  26. Taheri JB, Azimi S, Rafieian N, Zanjani HA. Herbs in dentistry. Int Dent J. 2011 Dec;61(6):287-96. doi: 10.1111/j.1875-595X.2011.00064.x. Epub 2011 Nov 3. PMID: 22117784; PMCID: PMC9374842.
  27. Safarabadi M, Ghaznavi-Rad E, Pakniyat A, Rezaie K, Jadidi A. Comparing the Effect of Echinacea and Chlorhexidine Mouthwash on the Microbial Flora of Intubated Patients Admitted to the Intensive Care Unit. Iran J Nurs Midwifery Res. 2017 Nov-Dec;22(6):481-485. doi: 10.4103/ijnmr.IJNMR_92_16. PMID: 29184589; PMCID: PMC5684798.
  28. Lima V, Melo IM, Taira TM, Buitrago LYW, Fonteles CSR, Leal LKAM, Souza ASQ, Almeida TS, Costa Filho RND, Moraes MO, Cunha FQ, Fukada SY. Uncaria tomentosa reduces osteoclastic bone loss in vivo. Phytomedicine. 2020 Dec;79:153327. doi: 10.1016/j.phymed.2020.153327. Epub 2020 Sep 2. PMID: 32920290.
  29. Ccahuana-Vasquez RA, Santos SS, Koga-Ito CY, Jorge AO. Antimicrobial activity of Uncaria tomentosa against oral human pathogens. Braz Oral Res. 2007 Jan-Mar;21(1):46-50. doi: 10.1590/s1806-83242007000100008. PMID: 17426895.
  30. Nedumaran N, Rajasekar A, Venkatakrishnan S, Wajeeha H. An In Vitro Study of Antioxidant, Anti-inflammatory, and Cytotoxic Effects of Echinacea-Mediated Zinc Oxide Nanoparticles. Cureus. 2024 Jul 25;16(7):e65354. doi: 10.7759/cureus.65354. PMID: 39184651; PMCID: PMC11344488.
  31. Campisi G, Bizzoca ME, Lo Muzio L. COVID-19 and periodontitis: reflecting on a possible association. Head Face Med. 2021 May 11;17(1):16. doi: 10.1186/s13005-021-00267-1. PMID: 33975613; PMCID: PMC8110692.
  32. Lai TM, Kuo PJ, Lin CY, Chin YT, Lin HL, Chiu HC, Fu MMJ, Fu E. CD147 self-regulates matrix metalloproteinase-2 release in gingival fibroblasts after coculturing with U937 monocytic cells. J Periodontol. 2020 May;91(5):651-660. doi: 10.1002/JPER.19-0278. Epub 2019 Oct 21. PMID: 31557319.
  33. Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020 Jun;53(3):368-370. doi: 10.1016/j.jmii.2020.03.005. Epub 2020 Mar 11. PMID: 32205092; PMCID: PMC7156211.
  34. Domingues A, Sartori A, Valente LM, Golim MA, Siani AC, Viero RM. Uncaria tomentosa aqueous-ethanol extract triggers an immunomodulation toward a Th2 cytokine profile. Phytother Res. 2011 Aug;25(8):1229-35. doi: 10.1002/ptr.3549. Epub 2011 Jun 8. PMID: 21656603.
  35. Núñez C, Lozada-Requena I, Ysmodes T, Zegarra D, Saldaña F, Aguilar J. Nmunomodulación de Uncaria tomentosa sobre células dendríticas, il-12 y perfil TH1/TH2/TH17 en cáncer de mama [Immunomodulation of Uncaria tomentosa over dendritic cells, il-12 and profile TH1/TH2/TH17 in breast cancer]. Rev Peru Med Exp Salud Publica. 2015 Oct;32(4):643-51. Spanish. PMID: 26732910.
  36. Capasso F. Farmacognosia: botanica, chimica e farmacologia delle piante medicinalli. 2nd ed. Milano: Springer; 2011. 489 p.
  37. Allen-Hall L, Arnason JT, Cano P, Lafrenie RM. Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappaB. J Ethnopharmacol. 2010 Feb 17;127(3):685-93. doi: 10.1016/j.jep.2009.12.004. Epub 2009 Dec 6. PMID: 19995599.
  38. Villegas Vilchez LF, Ascencios JH, Dooley TP. Prophylaxis and Treatment of Inflammation with Pentacyclic Chemotype of Uncaria tomentosa. Integr Med (Encinitas). 2023 Jul;22(3):22-27. PMID: 37534020; PMCID: PMC10393379.
  39. Reis SR, Valente LM, Sampaio AL, Siani AC, Gandini M, Azeredo EL, D'Avila LA, Mazzei JL, Henriques Md, Kubelka CF. Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue Virus-2. Int Immunopharmacol. 2008 Mar;8(3):468-76. doi: 10.1016/j.intimp.2007.11.010. Epub 2007 Dec 26. PMID: 18279801.
  40. Heitzman ME, Neto CC, Winiarz E, Vaisberg AJ, Hammond GB. Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae). Phytochemistry. 2005 Jan;66(1):5-29. doi: 10.1016/j.phytochem.2004.10.022. PMID: 15649507.
  41. Williams JE. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Altern Med Rev. 2001 Dec;6(6):567-79. PMID: 11804547.
  42. Caon T, Kaiser S, Feltrin C, de Carvalho A, Sincero TC, Ortega GG, Simões CM. Antimutagenic and antiherpetic activities of different preparations from Uncaria tomentosa (cat's claw). Food Chem Toxicol. 2014 Apr;66:30-5. doi: 10.1016/j.fct.2014.01.013. Epub 2014 Jan 18. PMID: 24447975.
  43. Shahzad M, Chen H, Akhtar T, Rafi A, Zafar MS, Zheng YT. Human immunodeficiency virus: The potential of medicinal plants as antiretroviral therapy. J Med Virol. 2022 Jun;94(6):2669-2674. doi: 10.1002/jmv.27648. Epub 2022 Feb 25. PMID: 35128696.
  44. Slots J. Periodontitis: facts, fallacies and the future. Periodontol 2000. 2017 Oct;75(1):7-23. doi: 10.1111/prd.12221. PMID: 28758294.
  45. Dioguardi M, Spirito F, Sovereto D, Ballini A, Alovisi M, Lo Muzio L. Application of the Extracts of Uncaria tomentosa in Endodontics and Oral Medicine: Scoping Review. J Clin Med. 2022 Aug 26;11(17):5024. doi: 10.3390/jcm11175024. PMID: 36078953; PMCID: PMC9457483.
  46. Ferreira AO, Polonini HC, Dijkers ECF. Postulated Adjuvant Therapeutic Strategies for COVID-19. J Pers Med. 2020 Aug 5;10(3):80. doi: 10.3390/jpm10030080. PMID: 32764275; PMCID: PMC7565841.
  47. Aguilar JL, Rojas P, Marcelo A, Plaza A, Bauer R, Reininger E, Klaas CA, Merfort I. Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae). J Ethnopharmacol. 2002 Jul;81(2):271-6. doi: 10.1016/s0378-8741(02)00093-4. PMID: 12065162.
  48. Azevedo BC, Morel LJF, Carmona F, Cunha TM, Contini SHT, Delprete PG, Ramalho FS, Crevelin E, Bertoni BW, França SC, Borges MC, Pereira AMS. Aqueous extracts from Uncaria tomentosa (Willd. ex Schult.) DC. reduce bronchial hyperresponsiveness and inflammation in a murine model of asthma. J Ethnopharmacol. 2018 May 23;218:76-89. doi: 10.1016/j.jep.2018.02.013. Epub 2018 Feb 10. PMID: 29432856.
  49. Yepes-Pérez AF, Herrera-Calderon O, Quintero-Saumeth J. Uncaria tomentosa (cat's claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling. J Biomol Struct Dyn. 2022 Mar;40(5):2227-2243. doi: 10.1080/07391102.2020.1837676. Epub 2020 Oct 29. PMID: 33118480; PMCID: PMC7657399.
  50. Yepes-Pérez AF, Herrera-Calderon O, Sánchez-Aparicio JE, Tiessler-Sala L, Maréchal JD, Cardona-G W. Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat's Claw) against the Main Protease 3CLpro of SARS-CoV-2 by Molecular Modeling. Evid Based Complement Alternat Med. 2020 Sep 30;2020:4932572. doi: 10.1155/2020/4932572. PMID: 33029165; PMCID: PMC7532411.
  51. Sarri Stefano. Uso dei prodotti naturali nelle patologie odontoiatriche. Vol. 1. AriesDue; 2020.
  52. Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C. Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea. Molecules. 2018 Oct 26;23(11):2778.
  53. Choi EM, Kim AJ, Kim YO, Hwang JK. Immunomodulating activity of arabinogalactan and fucoidan in vitro. J Med Food. 2005 Winter;8(4):446-53. doi: 10.1089/jmf.2005.8.446. PMID: 16379554.
  54. Hensel A, Bauer R, Heinrich M, Spiegler V, Kayser O, Hempel G, Kraft K. Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature. Planta Med. 2020 Jul;86(10):659-664. doi: 10.1055/a-1177-4396. Epub 2020 May 20. PMID: 32434254; PMCID: PMC7356065.
  55. Anand David AV, Arulmoli R, Parasuraman S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn Rev. 2016 Jul-Dec;10(20):84-89. doi: 10.4103/0973-7847.194044. PMID: 28082789; PMCID: PMC5214562.
  56. Smith M, Smith JC. Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface. Chemistry. 2020.
  57. Bui TM, Wiesolek HL, Sumagin R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol. 2020 Sep;108(3):787-799. doi: 10.1002/JLB.2MR0220-549R. Epub 2020 Mar 17. PMID: 32182390; PMCID: PMC7977775.
  58. Derosa G, Maffioli P, D'Angelo A, Di Pierro F. A role for quercetin in coronavirus disease 2019 (COVID-19). Phytother Res. 2021 Mar;35(3):1230-1236. doi: 10.1002/ptr.6887. Epub 2020 Oct 9. PMID: 33034398; PMCID: PMC7675685.
  59. Heinz SA, Henson DA, Austin MD, Jin F, Nieman DC. Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Pharmacol Res. 2010 Sep;62(3):237-42. doi: 10.1016/j.phrs.2010.05.001. Epub 2010 May 15. PMID: 20478383; PMCID: PMC7128946.
  60. Khalifa SAM, Yosri N, El-Mallah MF, Ghonaim R, Guo Z, Musharraf SG, Du M, Khatib A, Xiao J, Saeed A, El-Seedi HHR, Zhao C, Efferth T, El-Seedi HR. Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic. Phytomedicine. 2021 May;85:153311. doi: 10.1016/j.phymed.2020.153311. Epub 2020 Aug 29. PMID: 33067112; PMCID: PMC7455571.
  61. Llivisaca-Contreras SA, Naranjo-Morán J, Pino-Acosta A, Pieters L, Vanden Berghe W, Manzano P, et al. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2. Molecules. 2021 Jul 5;26(13):4099.
  62. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020 Apr 2;12(4):988. doi: 10.3390/nu12040988. PMID: 32252338; PMCID: PMC7231123.
  63. Yamasaki K, Kawanami T, Yatera K, Fukuda K, Noguchi S, Nagata S, Nishida C, Kido T, Ishimoto H, Taniguchi H, Mukae H. Significance of anaerobes and oral bacteria in community-acquired pneumonia. PLoS One. 2013 May 6;8(5):e63103. doi: 10.1371/journal.pone.0063103. PMID: 23671659; PMCID: PMC3646017.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership